Chronic Obstructive Pulmonary Disease, COPD Clinical Trial
Official title:
A 24-week, Double Blind, Randomized Study to Investigate the Effect of 500 µg Roflumilast Tablets Once Daily Versus Placebo on Parameters Indicative of Hyperinflation in Patients With Chronic Obstructive Pulmonary Disease
The purpose of this trial is to study the effects of roflumilast on lung function parameters indicative of hyperinflation in patients with COPD.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03064113 -
Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Completed |
NCT00496470 -
Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.
|
Phase 4 | |
Completed |
NCT02442206 -
Effect of QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) on Cardiac Function in COPD Patients
|
Phase 4 | |
Completed |
NCT03095456 -
Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD
|
Phase 3 | |
Completed |
NCT02615795 -
Tele Health Monitoring Service for Patients With Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02449018 -
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
|
Phase 2 |